These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 19758316

  • 1. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, Lee KH.
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [Abstract] [Full Text] [Related]

  • 2. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, Bieber T, Thomas WR, Valenta R, Zuberbier T, Sager A, Novak N.
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N.
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [Abstract] [Full Text] [Related]

  • 4. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
    Park CO, Lee HJ, Lee JH, Wu WH, Chang NS, Hua L, Lee MG, Lee KH.
    Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
    [Abstract] [Full Text] [Related]

  • 6. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y, Takehara K, Sato S.
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [Abstract] [Full Text] [Related]

  • 7. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W, Czarnecka-Operacz M.
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [Abstract] [Full Text] [Related]

  • 8. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 9. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC.
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [Abstract] [Full Text] [Related]

  • 10. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P.
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [Abstract] [Full Text] [Related]

  • 11. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
    Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF.
    Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
    [Abstract] [Full Text] [Related]

  • 13. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S, Nakamura K, Oyama N, Kaneko F, Tsunemi Y, Saeki H, Tamaki K.
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [Abstract] [Full Text] [Related]

  • 14. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW, Sohn MH, Kim ES, Kim KW, Kim KE.
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK, Chen WY, Huang JL, Lue KH, Wang JY.
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [Abstract] [Full Text] [Related]

  • 16. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [Abstract] [Full Text] [Related]

  • 17. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E.
    J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
    [Abstract] [Full Text] [Related]

  • 18. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P.
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [Abstract] [Full Text] [Related]

  • 19. Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis.
    Pucheu-Haston CM, Jackson HA, Olivry T, Dunston SM, Hammerberg B.
    Clin Exp Allergy; 2008 Apr; 38(4):667-79. PubMed ID: 18307530
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].
    Pacor ML, Biasi D, Maleknia T.
    Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.